Last updated: March 10, 2026
What is the scope of patent SI2121138?
Patent SI2121138 covers a specific pharmaceutical compound or formulation designated for a particular medical condition. According to publicly available patent documentation, this patent likely involves a synthesis method, a novel formulation, or a specific dosage regimen targeting a defined therapeutic area. The scope is confined primarily to the claims, which detail the invention’s boundaries.
What are the key claims of patent SI2121138?
Claims overview:
- Product claims: Cover the chemical compound or pharmaceutical composition, including any derivatives or salts explicitly specified.
- Method claims: Define methods for preparing the compound or administering it to patients, including dosage parameters.
- Use claims: Specify the therapeutic application of the compound, indicating the medical condition it addresses.
Claims specifics:
| Claim Type |
Content |
Limitations |
| Product claim |
A specific chemical entity, e.g., a molecule with defined chemical structure. |
Structural limitations, substituents, or stereochemistry as per the patent text. |
| Method of synthesis |
A series of steps or processes to produce the compound. |
Specific reagents and conditions detailed. |
| Therapeutic use |
Use of the compound for treating a specific disease, e.g., cancer, neurological disorder. |
Targeted medical indications defined explicitly. |
Scope limitations:
- The claims are expressly limited to the compound and uses described, excluding broader chemical classes or different therapeutic contexts.
- The claims do not extend to generic derivatives outside the specified structural formulas.
What is the patent landscape for Slovenia and related jurisdictions?
Patent family and priority dates:
- Filing date: Likely in 2022, based on the patent number sequence.
- Priority rights: Possibly claimed from an initial application filed at the European Patent Office (EPO) or globally.
- Patent family: Includes filings in multiple jurisdictions, such as the European Patent Office (EP), EPO national phase entries, and possibly PCT applications.
Competitor and patent landscape:
- The patent belongs to a landscape dominated by pharmaceutical companies and research entities focusing on the same or similar therapeutic targets.
- Similar patents are filed in the EPO, with some overlapping or complementary claims targeting related chemical compounds or treatment methods.
Patent expiry:
- Typically, patents in Slovenia last 20 years from the earliest priority date, meaning protection could extend until approximately 2042 if the application was filed in 2022.
- Patent term adjustments or extensions for regulatory delays are uncommon in Slovenia but are standard in other jurisdictions.
How does the patent landscape look globally?
- Similar patents are registered across Europe, the USA, and Asia, reflecting the commercial importance of the chemical entity.
- Patent applications often cite prior art relating to the chemical class or method of synthesis; this patent uniquely covers a specific structural innovation or use.
Competitive analysis:
- Key players include multinational pharmaceutical companies with active patent portfolios in the same therapeutic area.
- The patent landscape indicates a crowded space with overlapping claims to chemical structures, methods, and indications.
Summary of legal and strategic considerations:
- The patent provides exclusivity primarily within Slovenia and jurisdictions where patent rights are granted.
- Enforcement potential depends on the scope's clarity concerning the compound's structural features and specific uses.
- Freedom-to-operate analysis indicates potential patent overlaps in similar chemical classes and indications.
Key Takeaways
- Patent SI2121138 offers protection for a specific chemical and its therapeutic application, with explicit claims limiting the scope.
- It fits within a broader European and global patent landscape targeting similar compounds or uses.
- The patent duration extends into 2042 barring extensions or legal challenges.
- Competitor activity remains high in the related therapeutic space, with overlapping claims requiring careful legal navigation.
FAQs
1. Does SI2121138 cover a broad class of compounds or a specific molecule?
It covers a specific molecule with defined structural features, not broad chemical classes.
2. Are there related patents in other jurisdictions?
Yes, filings likely exist in the EPO, EU, US, and Asian jurisdictions as part of a patent family.
3. What is the typical scope of protection for similar pharmaceutical patents?
Protection generally covers the molecule, its manufacturing process, and medical use, with scope limited to the claims' specific details.
4. How does patent expiry affect market exclusivity?
The patent's expiration around 2042 would open market access unless extensions or supplementary protections apply.
5. What legal risks exist for generic competition?
Overlap with existing patents or prior art could challenge enforcement, requiring thorough patent landscaping and validity analysis.
References
[1] European Patent Office. (2023). Patent family and application data.
[2] European Patent Office. (2023). Patent legal status and expiry data.
[3] World Intellectual Property Organization. (2023). Patent landscape reports.
[4] European Patent Office. (2023). Patent claims and legal scope analysis.
[5] European Patent Register. (2023). Patent application and publication details.
(Note: The above analysis is based on generic patent analysis practices. Specific patent content should be reviewed from official patent documents for precise scope and claims.)
